|
Saturday,
5 November 2005, Pre-Meeting Short Courses |
FULL DAY COURSES 9:00 -18:00
Pharmacoeconomics and Outcomes Research
Pharmacoeconomics for Decision-Makers
Faculty:
Lorne Basskin PharmD,
Clinical Coordinator, Pharmacy
Services, North Shore Medical Center, Miami, FL, USA and
President, Trinka Publications, Cooper City, FL, USA
Course Description:
This course is designed to teach clinicians and new
researchers how to incorporate pharmacoeconomics into
study design and data analysis. Participants will learn
how to collect and calculate the costs of different
alternatives, determine the economic impact of clinical
outcomes, and how to identify, track and assign costs to
different types of health care resources used. The
development of economic protocols and data collection
sheets will be discussed. Different pharmacoeconomic
models and techniques will be demonstrated and practiced
in lectures and case studies. These include
cost-minimization, cost-of-illness, cost-effectiveness,
cost-benefit, and cost-utility analysis. Decision
analysis, sensitivity analysis, and discounting, will all
be demonstrated and practiced. Participants will also
learn to compare and evaluate interventions such as drugs,
devices and clinical services. This course is suitable
for those with little or no experience with
pharmacoeconomics.
MORNING COURSES 9:00 -13:00
Quality of Life / Patient-Reported Outcomes /
Preference-based Methods (AM) 9:00-13:00
Analysis and Interpretation of Quality of Life and Patient-Reported Outcomes
Faculty:
Linda Abetz
MA, Director, Questionnaire
Development and Validation, Mapi Values, Bollington, UK;
Christine de la Loge MS,
Director, Psychometrics and
Statistics, Mapi Values, Lyon, France
Course Description:
This
course is designed to provide a range of methods that may
help to solve common problems encountered with quality of
life / patient-reported outcomes. These include an
overview of psychometric validation methods (including a
brief overview of Rasch analysis), missing data analysis
techniques, and a variety of methods to assess minimally
clinically important differences. This course includes a
discussion of the ISPOR co-developed report:
“Incorporating The Patient's Perspective Into Drug
Development And Communication Report” as well as the
Principles of Good Practice for the Translation and
Cultural Adaptation Process for Patient-Reported
Outcomes (PRO) Measures: Report of the ISPOR Task Force
for Translation and Cultural Adaptation. Specific examples will
be used throughout the course and participants will be
asked to complete a short exercise. This course is
designed for individuals with little experience with
quality-of-life studies.
Pharmacoeconomics and Outcomes Research (AM)
9:00-13:00
European Databases and Retrospective Database Analysis
Faculty: Bernd Brϋggenjϋrgen MD, MPH,
Coordinator-Health Economics, University of Berlin,
Berlin, Germany
Course Description: Large
administrative patient databases provide a unique
opportunity to examine retrospectively the effects of
health care intervention use on clinical and economic
outcomes in "real world" settings. During this course,
databases in Europe and their characteristics will be
discussed. Issues when conducting retrospective database
analysis including statistical issues will be examined.
The ISPOR Checklist for Retrospective Database Studies,
a useful tool for assessing as well as conducting
retrospective studies, will be discussed. This course is
for those with little experience with European databases
and retrospective database analysis.
AFTERNOON COURSES
14:00 -18:00
Cost Studies (PM) 14:00-18:00
Cost Estimation and Assessing Financial (Budget) Impact of New
Health Care Technologies
Faculty:
Josephine Mauskopf
PhD, Global Head, Health Economics and Outcomes Strategy, RTI Health Solutions, Research Triangle Park, NC, USA; C.
Daniel Mullins PhD, Professor and Chair of Pharmaceutical
Health Services Research, University of Maryland, School
of Pharmacy, Baltimore, MD, USA
Course Description:
This course will describe methods to determine the costs
associated with a health condition and the budget impact
of new technologies for that condition. The course will
present incidence and prevalence based costing strategies.
Treatment algorithms and event-based approaches will be
demonstrated for disease-specific costs from different
decision-maker perspectives. Both static and dynamic
methods for estimating the budget impact of adding a new
drug to a health plan formulary will be presented. Issues
related to imputing missing data will also be discussed.
This course is designed for those with some experience
with pharmacoeconomic analysis.
Modeling (PM) 14:00-18:00
Pharmacoeconomic Modeling
Faculty: Uwe Siebert MD, MPH, MSc, ScD, Professor of Public
Health; Head of the Department of Public Health, Medical
Decision Making and Health Technology Assessment,
University of Health Sciences, Medical Informatics and
Technology, Hall/Innsbruck, Austria, and Associate
Professor of Radiology, Harvard Medical School, Director
of the Cardiovascular Research Program, Institute for
Technology Assessment, Massachusetts General Hospital,
Boston, MA, USA; Gaby Sroczynski MPH, Decision
Scientist, Institute for Technology Assessment,
Massachusetts General Hospital, Harvard Medical School,
Boston, MA, USA and Bavarian Public Health Research and
Coordinating Center, University Munich, Germany
Course Description:
This course will present an in-depth discussion of
advanced pharmacoeconomic modeling techniques such as
Monte Carlo analysis, Markov modeling, and probabilistic
sensitivity analysis including a review of the ISPOR
Principles of Good Practice for Decision Analytic
Modeling in Health Care Evaluations. This course is
designed for those with intermediate to advanced
experience with modeling techniques.
8th Annual European Congress Main Page |
